Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 345

1.

Evidence-based emergency medicine review. Prevention of contrast-induced nephropathy in the emergency department.

Sinert R, Doty CI.

Ann Emerg Med. 2007 Sep;50(3):335-45, 345.e1-2. Epub 2007 May 21. Review.

PMID:
17512638
2.

N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.

Zagler A, Azadpour M, Mercado C, Hennekens CH.

Am Heart J. 2006 Jan;151(1):140-5.

PMID:
16368307
3.

The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy.

Guru V, Fremes SE.

Clin Nephrol. 2004 Aug;62(2):77-83. Review.

PMID:
15356963
4.

Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.

Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC.

Ann Intern Med. 2008 Feb 19;148(4):284-94. Erratum in: Ann Intern Med. 2008 Aug 5;149(3):219.

PMID:
18283206
5.

Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

Bagshaw SM, Ghali WA.

Arch Intern Med. 2005 May 23;165(10):1087-93. Review.

PMID:
15911721
6.

Strategies to reduce the risk of contrast nephropathy: an evidence-based approach.

Pannu N, Tonelli M.

Curr Opin Nephrol Hypertens. 2006 May;15(3):285-90. Review.

PMID:
16609296
7.

Update: Prevention of contrast-induced nephropathy in the emergency department.

Sinert R, Doty CI.

Ann Emerg Med. 2009 Jul;54(1):e1-5. doi: 10.1016/j.annemergmed.2008.08.014. Epub 2008 Oct 16.

PMID:
18926598
8.

Contrast-induced kidney injury: focus on modifiable risk factors and prophylactic strategies.

Kagan A, Sheikh-Hamad D.

Clin Cardiol. 2010 Feb;33(2):62-6. doi: 10.1002/clc.20687. Review.

9.

[Contrast nephropathy and its prevention].

Skulec R, Bĕlohlávek J, Kovárník T, Linhart A, Aschermann M.

Vnitr Lek. 2003 Feb;49(2):127-33. Review. Czech.

PMID:
12728580
10.

Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials.

Dai B, Liu Y, Fu L, Li Y, Zhang J, Mei C.

Am J Kidney Dis. 2012 Sep;60(3):360-70. doi: 10.1053/j.ajkd.2012.02.332. Epub 2012 Apr 17. Review.

PMID:
22516682
11.

Contrast-induced nephropathy: pharmacological prophylaxis.

Briguori C, Marenzi G.

Kidney Int Suppl. 2006 Apr;(100):S30-8.

PMID:
16612399
12.

Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.

Majumdar SR, Kjellstrand CM, Tymchak WJ, Hervas-Malo M, Taylor DA, Teo KK.

Am J Kidney Dis. 2009 Oct;54(4):602-9. doi: 10.1053/j.ajkd.2009.03.024. Epub 2009 Jun 17.

PMID:
19535188
15.

Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis.

Ix JH, McCulloch CE, Chertow GM.

Nephrol Dial Transplant. 2004 Nov;19(11):2747-53. Epub 2004 Aug 24.

PMID:
15328384
16.

Contrast nephropathy : an evidence-based approach to prevention.

Kandzari DE, Rebeiz AG, Wang A, Sketch MH Jr.

Am J Cardiovasc Drugs. 2003;3(6):395-405. Review.

PMID:
14728060
17.

Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a review.

Walker PD, Brokering KL, Theobald JC.

Pharmacotherapy. 2003 Dec;23(12):1617-26. Review.

PMID:
14695041
18.

Prevention of contrast-induced nephropathy: a critical review.

Van Praet JT, De Vriese AS.

Curr Opin Nephrol Hypertens. 2007 Jul;16(4):336-47. Review.

PMID:
17565276
19.

Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.

Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, Okuda K, Iwasaki Y, Hori M, Fukunami M.

Am J Cardiol. 2007 Sep 1;100(5):781-6. Epub 2007 Jun 13.

PMID:
17719320
20.

Prevention of radiocontrast nephropathy.

Lin J, Bonventre JV.

Curr Opin Nephrol Hypertens. 2005 Mar;14(2):105-10. Review.

PMID:
15687835

Supplemental Content

Support Center